These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 30374749)

  • 1. Acceptable quality of life and low disease activity achievable among transition phase patients with rheumatic disease.
    Relas H; Kosola S
    Clin Rheumatol; 2019 Mar; 38(3):785-791. PubMed ID: 30374749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome of transition phase patients with juvenile idiopathic arthritis.
    Relas H; Luosujärvi R; Kosola S
    Mod Rheumatol; 2018 Sep; 28(5):832-837. PubMed ID: 29251024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patients with psychiatric diagnoses have lower quality of life than other patients with juvenile rheumatic disease: a prospective study.
    Kosola S; Relas H
    Rheumatology (Oxford); 2021 Dec; 60(12):5560-5566. PubMed ID: 33591311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transition to adult rheumatology care is necessary to maintain DMARD therapy in young people with juvenile idiopathic arthritis.
    Luque Ramos A; Hoffmann F; Albrecht K; Klotsche J; Zink A; Minden K
    Semin Arthritis Rheum; 2017 Oct; 47(2):269-275. PubMed ID: 28583690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health-related quality of life in patients with common rheumatic diseases referred to a university clinic.
    Laas K; Roine R; Räsänen P; Sintonen H; Leirisalo-Repo M;
    Rheumatol Int; 2009 Jan; 29(3):267-73. PubMed ID: 18682951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health-related quality of life during early aggressive treatment in patients with polyarticular juvenile idiopathic arthritis: results from randomized controlled trial.
    Tarkiainen M; Tynjälä P; Vähäsalo P; Kröger L; Aalto K; Lahdenne P
    Pediatr Rheumatol Online J; 2019 Dec; 17(1):80. PubMed ID: 31842940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disease activity, treatment and long-term prognosis of adult juvenile idiopathic arthritis patients compared with rheumatoid arthritis patients.
    Matsumoto T; Matsui T; Hirano F; Tohma S; Mori M
    Mod Rheumatol; 2020 Jan; 30(1):78-84. PubMed ID: 30499364
    [No Abstract]   [Full Text] [Related]  

  • 8. Long-Term Health-Related Quality of Life in German Patients with Juvenile Idiopathic Arthritis in Comparison to German General Population.
    Barth S; Haas JP; Schlichtiger J; Molz J; Bisdorff B; Michels H; Hügle B; Radon K
    PLoS One; 2016; 11(4):e0153267. PubMed ID: 27115139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcome of 114 adult JIA patients in a non-pediatric rheumatology institute in Japan.
    Miyamae T; Tanaka E; Kishi T; Matsuyama T; Igarashi T; Fujikawa S; Taniguchi A; Momohara S; Yamanaka H
    Mod Rheumatol; 2015 Jan; 25(1):62-6. PubMed ID: 25019624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health-related quality of life and disability in adults with juvenile idiopathic arthritis: comparison with adult-onset rheumatic diseases.
    Oliveira Ramos F; Rodrigues A; Magalhaes Martins F; Melo AT; Aguiar F; Brites L; Azevedo S; Duarte AC; Furtado C; Mourão AF; Sequeira G; Cunha I; Figueira R; Melo Gomes JA; Santos MJ; Fonseca JE
    RMD Open; 2021 Nov; 7(3):. PubMed ID: 34819385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spectrum of paediatric rheumatic disorders at a tertiary hospital in Tanzania.
    Furia FF; Godfrey E; Mwamanenge N; Swai P
    Pediatr Rheumatol Online J; 2020 Apr; 18(1):30. PubMed ID: 32245494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health-related quality of life among Swedish children with Juvenile Idiopathic Arthritis: parent-child discrepancies, gender differences and comparison with a European cohort.
    Lundberg V; Eriksson C
    Pediatr Rheumatol Online J; 2017 Apr; 15(1):26. PubMed ID: 28403864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapy of juvenile idiopathic arthritis in early adulthood with biologics: transition from pediatric to adult care].
    Niewerth M; Minden K; Klotsche J; Horneff G
    Z Rheumatol; 2014 Aug; 73(6):532-40. PubMed ID: 25096586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disease activity of idiopathic juvenile arthritis continues through adolescence despite the use of biologic therapies.
    Vidqvist KL; Malin M; Varjolahti-Lehtinen T; Korpela MM
    Rheumatology (Oxford); 2013 Nov; 52(11):1999-2003. PubMed ID: 23893666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement in health-related quality of life for children with juvenile idiopathic arthritis after start of treatment with etanercept.
    Klotsche J; Minden K; Thon A; Ganser G; Urban A; Horneff G
    Arthritis Care Res (Hoboken); 2014 Feb; 66(2):253-62. PubMed ID: 23983081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disease activity and dropout in young persons with juvenile idiopathic arthritis in transition of care: a longitudinal observational study.
    van Pelt PA; Dolhain RJEM; Kruize AA; Ammerlaan JJW; Hazes JW; Bijlsma JWJ; Wulffraat NM
    Clin Exp Rheumatol; 2018; 36(1):163-168. PubMed ID: 29461957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The majority of patients with newly diagnosed juvenile idiopathic arthritis achieve a health-related quality of life that is similar to that of healthy peers: results of the German multicenter inception cohort (ICON).
    Listing M; Mönkemöller K; Liedmann I; Niewerth M; Sengler C; Listing J; Foell D; Heiligenhaus A; Klein A; Horneff G; Ganser G; Haas JP; Klotsche J; Minden K
    Arthritis Res Ther; 2018 May; 20(1):106. PubMed ID: 29848349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of the timing of biological treatment initiation on Juvenile Idiopathic Arthritis long-term outcomes.
    Oliveira Ramos F; Rodrigues AM; Melo AT; Aguiar F; Brites L; Azevedo S; Duarte AC; Gomes JAM; Furtado C; Mourão AF; Sequeira G; Cunha I; Figueira R; Santos MJ; Fonseca JE
    Arthritis Res Ther; 2023 Sep; 25(1):177. PubMed ID: 37735435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of life and drug compliance: their interrelationship in rheumatic patients.
    Hromadkova L; Soukup T; Vlcek J
    J Eval Clin Pract; 2015 Oct; 21(5):919-24. PubMed ID: 26083391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Which patients with rheumatoid arthritis, spondyloarthritis, or juvenile idiopathic arthritis receive TNF-α antagonists in France? The CORPUS cohort study.
    Saraux A; Benichou J; Guillevin L; Idbrik L; Job-Deslandre C; Sibilia J; Soudant M; Wendling D; Guillemin F
    Clin Exp Rheumatol; 2015; 33(5):602-10. PubMed ID: 26315585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.